Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Stockholders' Equity

v3.22.1
Condensed Consolidated Statements of Stockholders' Equity - USD ($)
$ in Thousands
Total
Common Stock [Member]
Additional Paid-in Capital [Member]
Treasury Stock [Member]
Accumulated Other Comprehensive Loss [Member]
Accumulated Deficit [Member]
Beginning balance at Jan. 31, 2021 $ 31,541 $ 378 $ 246,446 $ (227) $ (73) $ (214,983)
Beginning balance, Shares at Jan. 31, 2021   37,811,224        
Issuance of common stock pursuant to vesting of restricted stock units   $ 2 (2)      
Issuance of common stock pursuant to vesting of restricted stock units, shares   178,096        
Issuance of common stock pursuant to exercise of stock options 137 $ 1 136      
Issuance of common stock pursuant to exercise of stock options, shares   95,538        
Issuance of common stock, net of issuance costs 17,462 $ 103 17,359      
Issuance of common stock, net of issuance costs, shares   10,323,484        
Stock-based compensation expense 208   208      
Unrealized gains on marketable securities 1       1  
Foreign currency translation adjustment 41       41  
Net loss (4,068)         (4,068)
Ending balance at Apr. 30, 2021 45,322 $ 484 264,147 (227) (31) (219,051)
Ending balance, Shares at Apr. 30, 2021   48,408,342        
Beginning balance at Jan. 31, 2022 42,524 $ 493 265,644 (227) (973) (222,413)
Beginning balance, Shares at Jan. 31, 2022   49,347,604        
Issuance of common stock pursuant to vesting of restricted stock units   $ 1 (1)      
Issuance of common stock pursuant to vesting of restricted stock units, shares   71,117        
Stock-based compensation expense 284   284      
Foreign currency translation adjustment (576)       (576)  
Net loss (2,996)         (2,996)
Ending balance at Apr. 30, 2022 $ 39,236 $ 494 $ 265,927 $ (227) $ (1,549) $ (225,409)
Ending balance, Shares at Apr. 30, 2022   49,418,721